Information  X 
Enter a valid email address

Company Name matching 'Active Biotech'

Date
Time Source
Company
Announcement
14 Nov 2018 8:30 pm GNW   Factsheet Active Biotech (0GQU) Active Biotech AB - Interim report January - September 2018
08 Nov 2018 12:00 pm GNW   Factsheet Active Biotech (0GQU) Active Biotech: New data from the Phase 2 LEGATO-HD study will be presented at HSG 2018
13 Sep 2018 10:00 am GNW   Factsheet Active Biotech (0GQU) Active Biotech: Data from the Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be presented at "European Huntington's Disease Network (EHDN) plenary meeting 2018"
05 Sep 2018 7:30 am GNW   Factsheet Active Biotech (0GQU) Active Biotech regains global rights to development and commercialization of laquinimod
09 Aug 2018 7:30 am GNW   Factsheet Active Biotech (0GQU) Active Biotech AB - Interim Report January - June 2018
31 Jul 2018 8:15 am GNW   Factsheet Active Biotech (0GQU) Active Biotech provides update on laquinimod in Huntington's disease
31 May 2018 7:30 am GNW   Factsheet Active Biotech (0GQU) Number of shares and votes in Active Biotech
18 May 2018 7:30 am GNW   Factsheet Active Biotech (0GQU) Annual General Meeting of Active Biotech AB
17 May 2018 3:00 pm GNW   Factsheet Active Biotech (0GQU) Active Biotech AB Interim report January - March 2018
23 Apr 2018 10:30 am GNW   Factsheet Active Biotech (0GQU) Annual Report 2017 Active Biotech AB (publ)
18 Apr 2018 3:10 pm GNW   Factsheet Active Biotech (0GQU) Active Biotech: Notice of Annual General Meeting of Shareholders
12 Apr 2018 12:00 pm GNW   Factsheet Active Biotech (0GQU) Active Biotech's partner NeoTX presents new data at AACR demonstrating that ANYARA enhances the efficacy of checkpoint blockade in preclinical models of cancer
15 Feb 2018 7:40 am GNW   Factsheet Active Biotech (0GQU) NOTICE OF EXTRAORDINARY SHAREHOLDERS' MEETING
  7:30 am GNW   Factsheet Active Biotech (0GQU) Active Biotech AB Year-end report January - December 2017
20 Dec 2017 2:00 pm GNW   Factsheet Active Biotech (0GQU) Active Biotech provides updated information about the company's financial position
07 Dec 2017 6:00 pm GNW   Factsheet Active Biotech (0GQU) Active Biotech provides updated information about the company's financial position - the company currently lacks funding to ensure its operations for the coming twelve-month period
01 Dec 2017 12:00 pm GNW   Factsheet Active Biotech (0GQU) Active Biotech announce results in ARPEGGIO Phase II trial with laquinimod in Primary Progressive MS
17 Nov 2017 7:30 am GNW   Factsheet Active Biotech (0GQU) Active Biotech's election committee appointed
09 Nov 2017 7:30 am GNW   Factsheet Active Biotech (0GQU) Active Biotech AB - Interim report January - September 2017
19 Oct 2017 1:00 pm GNW   Factsheet Active Biotech (0GQU) Active Biotech's partner Teva presents new data on laquinimod for the treatment of multiple sclerosis at 7th joint ECTRIMS-ACTRIMS Meeting
10 Aug 2017 7:30 am GNW   Factsheet Active Biotech (0GQU) Active Biotech AB - Interim report January - June 2017
19 Jun 2017 2:30 pm GNW   Factsheet Active Biotech (0GQU) Helén Tuvesson new CEO of Active Biotech AB from July 1, 2017
16 Jun 2017 7:30 am GNW   Factsheet Active Biotech (0GQU) Annual General Meeting of Active Biotech AB
17 May 2017 7:30 am GNW   Factsheet Active Biotech (0GQU) Active Biotech: Notice of Annual General Meeting of Shareholders
27 Apr 2017 7:30 am GNW   Factsheet Active Biotech (0GQU) Active Biotech: Interim report January - March 2017
12 Apr 2017 12:30 pm GNW   Factsheet Active Biotech (0GQU) Active Biotech: FDA grants Orphan Drug Designation for tasquinimod for the treatment of multiple myeloma
16 Feb 2017 7:30 am GNW   Factsheet Active Biotech (0GQU) Active Biotech AB Year-end report January - December 2016
09 Jan 2017 12:00 pm GNW   Factsheet Active Biotech (0GQU) The European Patent Office grants patent for tasquinimod for treatment of multiple myeloma
30 Dec 2016 7:30 am GNW   Factsheet Active Biotech (0GQU) Number of shares and votes in Active Biotech
12 Dec 2016 4:31 pm GNW   Factsheet Active Biotech (0GQU) Active Biotech's rights issue completed
22 Nov 2016 2:05 pm GNW   Factsheet Active Biotech (0GQU) Active Biotech's election committee appointed
18 Nov 2016 2:15 pm GNW   Factsheet Active Biotech (0GQU) Prospectus relating to Active Biotech's rights issue published
11 Nov 2016 6:01 pm GNW   Factsheet Active Biotech (0GQU) Active Biotech carries out rights issue of approximately SEK 55 million
  6:00 pm GNW   Factsheet Active Biotech (0GQU) Active Biotech AB Interim report January - September 2016
26 Oct 2016 7:31 am GNW   Factsheet Active Biotech (0GQU) Active Biotech and NeoTX enter into a partnership for the development and commercialization of ANYARA for immuno-oncology
  7:25 am GNW   Factsheet Active Biotech (0GQU) Active Biotech postpone publication of the interim report
19 Sep 2016 7:30 am GNW   Factsheet Active Biotech (0GQU) Active Biotech update on laquinimod Development: The U.S, Food and Drug administration rescinds the Special Protocol Assessment for laquinimod
25 Jun 2015 1:01 pm GNW   Factsheet Active Biotech (0GQU) Teva and Active Biotech Announce Completion of Patient Enrollment in Laquinimod Phase III CONCERTO Trial
12 Jun 2015 7:30 am GNW   Factsheet Active Biotech (0GQU) Annual General Meeting of Active Biotech AB
01 Jun 2015 9:01 am GNW   Factsheet Active Biotech (0GQU) Active Biotech focuses the operations on the laquinimod project and adjusts the organization
12 May 2015 7:30 am GNW   Factsheet Active Biotech (0GQU) Notice of Annual General Meeting of Shareholders
30 Apr 2015 9:01 am GNW   Factsheet Active Biotech (0GQU) Annual Report 2014 Active Biotech AB (publ)
23 Apr 2015 7:00 pm GNW   Factsheet Active Biotech (0GQU) Teva and Active Biotech Announce First Patient Enrolled in Phase II Study Evaluating Laquinimod for Primary Progressive MS
  7:31 am GNW   Factsheet Active Biotech (0GQU) Active Biotech AB Interim report January - March 2015
16 Apr 2015 6:02 am GNW   Factsheet Active Biotech (0GQU) Active Biotech and Ipsen announce their decision to discontinue the development of tasquinimod in prostate cancer
11 Feb 2015 7:30 am GNW   Factsheet Active Biotech (0GQU) Active Biotech AB Year-end report January - December 2014
30 Jan 2015 7:30 am GNW   Factsheet Active Biotech (0GQU) Number of shares and votes in Active Biotech
12 Jan 2015 7:30 am GNW   Factsheet Active Biotech (0GQU) Active Biotech to Present at the 33rd Annual J.P. Morgan Healthcare Conference
29 Dec 2014 2:30 pm GNW   Factsheet Active Biotech (0GQU) Active Biotech's rights issue of approximately ...
09 Dec 2014 7:30 am GNW   Factsheet Active Biotech (0GQU) Active Biotech's election committee appointed
05 Dec 2014 7:30 am GNW   Factsheet Active Biotech (0GQU) Prospectus relating to Active Biotech's rights ...
01 Dec 2014 5:15 pm GNW   Factsheet Active Biotech (0GQU) Extraordinary General Meeting of Active Biotech...
05 Nov 2014 7:32 am GNW   Factsheet Active Biotech (0GQU) Active Biotech AB: Notice of Extraordinary Gene...
  7:31 am GNW   Factsheet Active Biotech (0GQU) Active Biotech strengthens its financial positi...
  7:30 am GNW   Factsheet Active Biotech (0GQU) Active Biotech AB Interim report January - Sept...
04 Nov 2014 1:00 pm GNW   Factsheet Active Biotech (0GQU) Teva and Active Biotech Announce Expansion of L...
12 Sep 2014 1:00 pm GNW   Factsheet Active Biotech (0GQU) Teva Presents New Clinical Safety Data in RRMS ...
14 Aug 2014 7:31 am GNW   Factsheet Active Biotech (0GQU) Active Biotech's partner Teva initiates a laqui...
07 Aug 2014 7:30 am GNW   Factsheet Active Biotech (0GQU) Active Biotech AB Interim report January-June 2014
11 Jun 2014 7:30 am GNW   Factsheet Active Biotech (0GQU) Active Biotech presents data on paquinimod at E...


Company Announcements Archive »

 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t